Vaccine Research: Läkaruppropet (The Doctor’s Call)

Press Release

November 5, 2021

Research fraud at a Pfizer subcontractor - now 16 doctors and researchers demand that vaccination in Sweden be paused.

The British Medical Journal (BMJ) revealed on November 2, 2021 that a subcontractor to Pfizer had likely conducted extensive research fraud during the Phase III study of Pfizer's covid vaccine in the fall of 2020. The article's main witness is Brook Jackson, who in September 2020, was the regional manager in Texas for the research organisation Ventavia Research Group, which worked with Pfizer's vaccine studies. Jackson's testimony states that the company falsified data, unblinded patients, hired inadequately trained vaccinators and was slow to follow up on side effects reported in the Phase III study. The staff who performed quality checks were overwhelmed by the number of problems they discovered.

After repeatedly informing Ventavia of these shortcomings, Brook Jackson sent an e-mail of complaint to the FDA (US Food and Drug Administration) on September 25, 2020. Ventavia fired her later that day. To support her concerns, Jackson has provided BMJ with dozens of internal company documents, photos, audio recordings and emails. BMJ substantiates her testimony with statements from many former employees at Ventavia.

The article also states that the FDA never inspected the operations where Brook Jackson worked. The article states the FDA has too few resources to inspect clinical trials. In the years 2000 to 2005, only about 1 percent of all studies were inspected, since then the number of inspections has decreased. In August 2021, the FDA published a summary of the number of inspections of Pfizer's covid vaccine studies. A total of 9 of 153 study sites had been inspected, which corresponds to 6 percent of the study's research centers.

We believe that what BMJ reported is extremely serious. This overturns confidence in Pfizer, which is responsible for testing the vaccine and for the safety of the vaccine currently used by Swedes, of whom hundreds of thousands are children.

The extent of the number of reported suspected side effects of the covid vaccine is also gigantic, for example in Sweden during the ten months the vaccination has taken place 83,744 suspected side effects have been reported, which is more than 10 times all side effects reported per year during the most recent years for all drugs and vaccines, a total of about 25,000 substances.

About twenty studies have shown that the effect of the vaccine is very weak. One of these studies, which is Swedish, showed that the vaccine had a good effect for about two months, that AstraZeneca's vaccine had no effect against the delta variant after four months and that the same applied to Pfizer's vaccine after seven months.

The strong suspicion that parts of the clinical trial of Pfizer's vaccine have not been performed in a scientifically acceptable manner and hence the study results cannot be considered reliable, combined with the large scale of reported suspected side effects after vaccination, many of a serious nature, make us - doctors, researchers and immunologists - deeply concerned. Not least for children who are at extremely low risk of serious illness with covid-19, but who risk serious vaccine side effects. The fact that the vaccine's effect subsides sharply after a few months and is weak against the delta variant of the virus contributes to our conclusion that covid vaccination in Sweden should be paused until risk / benefit calculations are made for all age groups. Our position is taken in light of the revelations in BMJ and what we know today about the risks for the patient.

Nils Littorin, physician; doctor of clinical microbiology

Magnus Burling, specialist in general medicine

Sture Blomberg, specialist in anesthesia and intensive care; lecturer

Ragnar Hultborn, specialist in oncology; professor emeritus

Lilian Weiss, specialist in general surgery; lecturer

Ann-Cathrin Engwall, immunologist and virologist; doctor of molecular cell biology with an immunological focus

Sebastian Rushworth, AT Physician

Maria Papadopoulou, ophthalmologist

Carina Ljungfelt, specialist in general medicine

Christina Malm, specialist in general medicine

Bo Jonsson, specialist in general psychiatry

Anette Stahel, PhD in biomedicine

Nina Yderberg, specialist in child and adolescent psychiatry

Dinu Dusceac, specialist in cardiology

Margareta Andersson, specialist in general medicine

Hanna Åsberg, specialist in general medicine